Columbus, Ohio-based IncludeHealth, Inc. is partnering with New Haven, Connecticut-based Yale New Haven Health System (YNHH) to bring virtual physical therapy to patients’ homes.
Partnership Delivers Virtual Physical Therapy to Patients’ Homes

IncludeHealth is a digital musculoskeletal (MSK) health company. Its MSK operating system (MSK-OS™) enables healthcare providers to deliver onsite and remote MSK care.
IncludeHealth and Yale New Haven Health began their partnership earlier this year at Yale New Haven Hospital. The goal of the partnership is to deliver a hybrid MSK care model to Yale New Haven Health’s patients, supplementing its in-person orthopedic services with MSK-OS to provide in-home virtual physical therapy. Utilizing the platform, clinicians will be able to remotely monitor patient progress and remotely adjust care plans.
IncludeHealth CEO Ryan Eder told OTW, “IncludeHealth and YNHH share the same vision of convenient, comprehensive care. Pairing their renowned expertise with our platform unlocks this powerful combination.”
Eder explained that in the upcoming year, “With continued/expanded support for Remote Therapeutic Monitoring and increased value-based care arrangements in 2023, our focus is supporting providers, payers and government for a broad expansion into hybrid MSK care.”
MSK-OS, a cloud-based digital platform, is HIPAA compliant. Per the press release, MSK-OS is a “hardware-free, device-agnostic platform.” It combines “the most accessible, measurable body tracking technology with proprietary clinical intelligence and tools to transform virtual MSK care delivery.”
Utilizing the platform, clinicians are able to monitor patient movement data in real-time. This means that patient progress can be continuously tracked outside of the clinic.
IncludeHealth collaborated with Google and other clinical partners to build its MSK-OS platform. For OTW’s coverage of the development of the MSK-OS platform, see “Google and IncludeHealth Launch Orthopedic ‘Operating System.’”
Since 2021 the technology has been used by physical therapy, orthopedics, and health systems partners. According to the press release, the parties are “excited for the potential to scale this model across the health system in the future.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.